Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsPayablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CervoMed (CRVO) Preferred Stock Liabilities (2022)

CervoMed (CRVO) has disclosed Preferred Stock Liabilities for 1 consecutive years, with $24.3 million as the latest value for Q4 2022.

  • Quarterly Preferred Stock Liabilities changed N/A to $24.3 million in Q4 2022 from the year-ago period, while the trailing twelve-month figure was $24.3 million through Dec 2022, changed N/A year-over-year, with the annual reading at $24.3 million for FY2022, N/A changed from the prior year.
  • Preferred Stock Liabilities hit $24.3 million in Q4 2022 for CervoMed.
  • In the past five years, Preferred Stock Liabilities ranged from a high of $24.3 million in Q4 2022 to a low of $24.3 million in Q4 2022.